Intellia Therapeutics, Inc. (NTLA)

9.56 +0.14 (+1.49%) USD  |  NASDAQ  |  Dec 24, 12:34
More

Intellia Therapeutics SG&A Expense (TTM): 119.17M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 304.67M
Regeneron Pharmaceuticals, Inc. 2.717B
Beam Therapeutics, Inc. 110.20M
Vertex Pharmaceuticals, Inc. 1.644B
Pacific Biosciences of California, Inc. 149.08M